{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T06:45:25Z","timestamp":1763448325694,"version":"3.45.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["24PRE1191760"],"award-info":[{"award-number":["24PRE1191760"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01-HL149704"],"award-info":[{"award-number":["R01-HL149704"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Skeletal Muscle"],"DOI":"10.1186\/s13395-025-00402-5","type":"journal-article","created":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T17:36:57Z","timestamp":1763401017000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pirfenidone treatment improves ischemic muscle function in mice with chronic kidney disease"],"prefix":"10.1186","volume":"15","author":[{"given":"Nicholas","family":"Balestrieri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gengfu","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terence E.","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,17]]},"reference":[{"issue":"3","key":"402_CR1","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1161\/01.CIR.0000114519.75433.DD","volume":"109","author":"AM O\u2019Hare","year":"2004","unstructured":"O\u2019Hare AM, Glidden DV, Fox CS, Hsu CY. High prevalence of peripheral arterial disease in persons with renal insufficiency: results from the National health and nutrition examination survey 1999\u20132000. Circulation. 2004;109(3):320\u20133.","journal-title":"Circulation"},{"issue":"2 Suppl 1","key":"402_CR2","first-page":"S86","volume":"9","author":"GJ Wang","year":"2016","unstructured":"Wang GJ, Shaw PA, Townsend RR, Anderson AH, Xie D, Wang X, et al. Sex differences in the incidence of peripheral artery disease in the chronic renal insufficiency cohort. Circ Cardiovasc Qual Outcomes. 2016;9(2 Suppl 1):S86-93.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"402_CR3","unstructured":"USRDS Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. 2022.\u00a0https:\/\/usrds-adr.niddk.nih.gov\/2022."},{"issue":"2","key":"402_CR4","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1681\/ASN.2004050409","volume":"16","author":"AM O\u2019Hare","year":"2005","unstructured":"O\u2019Hare AM, Bertenthal D, Shlipak MG, Sen S, Chren MM. Impact of renal insufficiency on mortality in advanced lower extremity peripheral arterial disease. J Am Soc Nephrol. 2005;16(2):514\u20139.","journal-title":"J Am Soc Nephrol"},{"issue":"12","key":"402_CR5","doi-asserted-by":"publisher","first-page":"3525","DOI":"10.1093\/ndt\/gfl470","volume":"21","author":"A Guerrero","year":"2006","unstructured":"Guerrero A, Montes R, Munoz-Terol J, Gil-Peralta A, Toro J, Naranjo M, et al. Peripheral arterial disease in patients with stages IV and V chronic renal failure. Nephrol Dial Transplant. 2006;21(12):3525\u201331.","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"402_CR6","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1111\/j.1365-2796.2007.01863.x","volume":"262","author":"L Pasqualini","year":"2007","unstructured":"Pasqualini L, Schillaci G, Pirro M, Vaudo G, Siepi D, Innocente S, et al. Renal dysfunction predicts long-term mortality in patients with lower extremity arterial disease. J Intern Med. 2007;262(6):668\u201377.","journal-title":"J Intern Med"},{"key":"402_CR7","doi-asserted-by":"crossref","unstructured":"Liew YP, Bartholomew JR, Demirjian S, Michaels J, Schreiber MJ Jr. Combined effect of chronic kidney disease and peripheral arterial disease on all-cause mortality in a high-risk population. Clin J Am Soc Nephrol. 2008;3(4):1084\u20139.","DOI":"10.2215\/CJN.04411007"},{"issue":"4","key":"402_CR8","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1016\/j.jvs.2013.04.007","volume":"58","author":"P Lacroix","year":"2013","unstructured":"Lacroix P, Aboyans V, Desormais I, Kowalsky T, Cambou JP, Constans J, et al. Chronic kidney disease and the short-term risk of mortality and amputation in patients hospitalized for peripheral artery disease. J Vasc Surg. 2013;58(4):966\u201371.","journal-title":"J Vasc Surg"},{"issue":"4","key":"402_CR9","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.jvs.2003.11.038","volume":"39","author":"AM O\u2019Hare","year":"2004","unstructured":"O\u2019Hare AM, Sidawy AN, Feinglass J, Merine KM, Daley J, Khuri S, et al. Influence of renal insufficiency on limb loss and mortality after initial lower extremity surgical revascularization. J Vasc Surg. 2004;39(4):709\u201316.","journal-title":"J Vasc Surg"},{"issue":"1","key":"402_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-017-0711-6","volume":"18","author":"MR Kaminski","year":"2017","unstructured":"Kaminski MR, Raspovic A, McMahon LP, Lambert KA, Erbas B, Mount PF, et al. Factors associated with foot ulceration and amputation in adults on dialysis: a cross-sectional observational study. BMC Nephrol. 2017;18(1):293.","journal-title":"BMC Nephrol"},{"issue":"1","key":"402_CR11","doi-asserted-by":"publisher","first-page":"15547","DOI":"10.1038\/s41598-019-52107-7","volume":"9","author":"FN Berru","year":"2019","unstructured":"Berru FN, Gray SE, Thome T, Kumar RA, Salyers ZR, Coleman M, et al. Chronic kidney disease exacerbates ischemic limb myopathy in mice via altered mitochondrial energetics. Sci Rep. 2019;9(1):15547.","journal-title":"Sci Rep"},{"issue":"2","key":"402_CR12","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1161\/CIRCRESAHA.123.322875","volume":"133","author":"N Balestrieri","year":"2023","unstructured":"Balestrieri N, Palzkill V, Pass C, Tan J, Salyers ZR, Moparthy C, et al. Activation of the aryl hydrocarbon receptor in muscle exacerbates ischemic pathology in chronic kidney disease. Circ Res. 2023;133(2):158\u201376.","journal-title":"Circ Res"},{"issue":"1","key":"402_CR13","first-page":"H44","volume":"326","author":"VR Palzkill","year":"2024","unstructured":"Palzkill VR, Tan J, Yang Q, Morcos J, Laitano O, Ryan TE. Deletion of the aryl hydrocarbon receptor in endothelial cells improves ischemic angiogenesis in chronic kidney disease. Am J Physiol Heart Circ Physiol. 2024;326(1):H44-60.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"7","key":"402_CR14","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1161\/CIRCRESAHA.124.325642","volume":"136","author":"K Kim","year":"2025","unstructured":"Kim K, Thome T, Pass C, Stone L, Vugman N, Palzkill V, et al. Multiomic analysis of calf muscle in peripheral artery disease and chronic kidney disease. Circ Res. 2025;136(7):688\u2013703.","journal-title":"Circ Res"},{"key":"402_CR15","doi-asserted-by":"publisher","DOI":"10.1172\/JCI142260","author":"NV Arinze","year":"2022","unstructured":"Arinze NV, Yin WQ, Lotfollahzadeh S, Napoleon MA, Richards S, Walker JA, et al. Tryptophan metabolites suppress the Wnt pathway and promote adverse limb events in chronic kidney disease. J Clin Invest. 2022. https:\/\/doi.org\/10.1172\/JCI142260.","journal-title":"J Clin Invest"},{"issue":"3","key":"402_CR16","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1177\/1358863X18824654","volume":"24","author":"NV Arinze","year":"2019","unstructured":"Arinze NV, Gregory A, Francis JM, Farber A, Chitalia VC. Unique aspects of peripheral artery disease in patients with chronic kidney disease. Vasc Med. 2019;24(3):251\u201360.","journal-title":"Vasc Med"},{"issue":"6","key":"402_CR17","doi-asserted-by":"publisher","first-page":"F1658","DOI":"10.1152\/ajprenal.00314.2018","volume":"315","author":"MK Abramowitz","year":"2018","unstructured":"Abramowitz MK, Paredes W, Zhang K, Brightwell CR, Newsom JN, Kwon HJ, et al. Skeletal muscle fibrosis is associated with decreased muscle inflammation and weakness in patients with chronic kidney disease. Am J Physiol Ren Physiol. 2018;315(6):F1658\u201369.","journal-title":"Am J Physiol Ren Physiol"},{"key":"402_CR18","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.150112","author":"CR Brightwell","year":"2021","unstructured":"Brightwell CR, Kulkarni AS, Paredes W, Zhang KH, Perkins JB, Gatlin KJ, et al. Muscle fibrosis and maladaptation occur progressively in CKD and are rescued by dialysis. JCI Insight. 2021. https:\/\/doi.org\/10.1172\/jci.insight.150112.","journal-title":"JCI Insight"},{"key":"402_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9123974","author":"GZ Cong","year":"2020","unstructured":"Cong GZ, Cui XD, Ferrari R, Pipinos II, Casale GP, Chattopadhyay A, et al. Fibrosis distinguishes critical limb ischemia patients from claudicants in a transcriptomic and histologic analysis. J Clin Med. 2020. https:\/\/doi.org\/10.3390\/jcm9123974.","journal-title":"J Clin Med"},{"issue":"9","key":"402_CR20","doi-asserted-by":"publisher","first-page":"2322","DOI":"10.1161\/ATVBAHA.120.314824","volume":"40","author":"N Ding","year":"2020","unstructured":"Ding N, Yang C, Ballew SH, Kalbaugh CA, McEvoy JW, Salameh M, et al. Fibrosis and inflammatory markers and long-term risk of peripheral artery disease the ARIC study. Arterioscler Thromb Vasc Biol. 2020;40(9):2322\u201331.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"402_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9082575","author":"CJ Mietus","year":"2020","unstructured":"Mietus CJ, Lackner TJ, Karvelis PS, Willcockson GT, Shields CM, Lambert NG, et al. Abnormal microvascular architecture, fibrosis, and pericyte characteristics in the calf muscle of peripheral artery disease patients with claudication and critical limb ischemia. J Clin Med. 2020. https:\/\/doi.org\/10.3390\/jcm9082575.","journal-title":"J Clin Med"},{"issue":"1","key":"402_CR22","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.kint.2016.07.029","volume":"91","author":"J Dong","year":"2017","unstructured":"Dong J, Dong Y, Chen Z, Mitch WE, Zhang L. The pathway to muscle fibrosis depends on myostatin stimulating the differentiation of fibro\/adipogenic progenitor cells in chronic kidney disease. Kidney Int. 2017;91(1):119\u201328.","journal-title":"Kidney Int"},{"key":"402_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-016-0790-3","author":"DM Ha","year":"2016","unstructured":"Ha DM, Carpenter LC, Koutakis P, Swanson SA, Zhu Z, Hanna M, et al. Transforming growth factor-beta 1 produced by vascular smooth muscle cells predicts fibrosis in the gastrocnemius of patients with peripheral artery disease. J Transl Med. 2016. https:\/\/doi.org\/10.1186\/s12967-016-0790-3.","journal-title":"J Transl Med"},{"key":"402_CR24","doi-asserted-by":"crossref","unstructured":"King TE Jr., Bradford WZ, Castro-Bernardini S, Fagan EA, Glaspole I, Glassberg MK, et al. A phase 3 trial of Pirfenidone in patients with idiopathic pulmonary fibrosis. N Engl J Med. 2014;370(22):2083\u201392.","DOI":"10.1056\/NEJMoa1402582"},{"issue":"22","key":"402_CR25","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1056\/NEJMoa1402584","volume":"370","author":"L Richeldi","year":"2014","unstructured":"Richeldi L, du Bois RM, Raghu G, Azuma A, Brown KK, Costabel U, et al. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med. 2014;370(22):2071\u201382.","journal-title":"N Engl J Med"},{"issue":"1","key":"402_CR26","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/nep.13180","volume":"23","author":"V Diwan","year":"2018","unstructured":"Diwan V, Brown L, Gobe GC. Adenine-induced chronic kidney disease in rats. Nephrology. 2018;23(1):5\u201311.","journal-title":"Nephrology"},{"issue":"17","key":"402_CR27","first-page":"4726","volume":"54","author":"X Wang","year":"1994","unstructured":"Wang X, Fu X, Brown PD, Crimmin MJ, Hoffman RM. Matrix metalloproteinase inhibitor BB-94 (batimastat) inhibits human colon tumor growth and spread in a patient-like orthotopic model in nude mice. Cancer Res. 1994;54(17):4726\u20138.","journal-title":"Cancer Res"},{"issue":"9","key":"402_CR28","doi-asserted-by":"publisher","first-page":"2470","DOI":"10.1093\/hmg\/ddv008","volume":"24","author":"JM Spinazzola","year":"2015","unstructured":"Spinazzola JM, Smith TC, Liu M, Luna EJ, Barton ER. Gamma-sarcoglycan is required for the response of archvillin to mechanical stimulation in skeletal muscle. Hum Mol Genet. 2015;24(9):2470\u201381.","journal-title":"Hum Mol Genet"},{"issue":"3","key":"402_CR29","doi-asserted-by":"publisher","first-page":"H424","DOI":"10.1152\/ajpheart.00121.2022","volume":"323","author":"ZR Salyers","year":"2022","unstructured":"Salyers ZR, Coleman M, Le D, Ryan TE. AAV-mediated expression of PFKFB3 in myofibers, but not endothelial cells, improves ischemic muscle function in mice with critical limb ischemia. Am J Physiol Heart Circ Physiol. 2022;323(3):H424-36.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1","key":"402_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s13395-023-00323-1","volume":"13","author":"A Danckaert","year":"2023","unstructured":"Danckaert A, Trignol A, Le Loher G, Loubens S, Staels B, Duez H, et al. Musclej2: a rebuilding of Musclej with new features for high-content analysis of skeletal muscle immunofluorescence slides. Skelet Muscle. 2023;13(1):14.","journal-title":"Skelet Muscle"},{"issue":"3","key":"402_CR31","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1159\/000183992","volume":"44","author":"T Yokozawa","year":"1986","unstructured":"Yokozawa T, Zheng PD, Oura H, Koizumi F. Animal model of adenine-induced chronic renal failure in rats. Nephron. 1986;44(3):230\u20134.","journal-title":"Nephron"},{"issue":"11","key":"402_CR32","doi-asserted-by":"publisher","first-page":"F1169","DOI":"10.1152\/ajprenal.00676.2013","volume":"307","author":"V Diwan","year":"2014","unstructured":"Diwan V, Small D, Kauter K, Gobe GC, Brown L. Gender differences in adenine-induced chronic kidney disease and cardiovascular complications in rats. Am J Physiol-Ren Physiol. 2014;307(11):F1169-78.","journal-title":"Am J Physiol-Ren Physiol"},{"key":"402_CR33","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.139826","author":"T Thome","year":"2021","unstructured":"Thome T, Kumar RA, Burke SK, Khattri RB, Salyers ZR, Kelley RC, et al. Impaired muscle mitochondrial energetics is associated with uremic metabolite accumulation in chronic kidney disease. JCI Insight. 2021. https:\/\/doi.org\/10.1172\/jci.insight.139826.","journal-title":"JCI Insight"},{"issue":"1","key":"402_CR34","doi-asserted-by":"publisher","first-page":"F106","DOI":"10.1152\/ajprenal.00117.2021","volume":"321","author":"K Kim","year":"2021","unstructured":"Kim K, Anderson EM, Thome T, Lu GY, Salyers ZR, Cort TA, et al. Skeletal myopathy in CKD: a comparison of adenine-induced nephropathy and 5\/6 nephrectomy models in mice. Am J Physiol-Renal. 2021;321(1):F106\u201319.","journal-title":"Am J Physiol-Renal"},{"issue":"1","key":"402_CR35","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1152\/physrev.00015.2007","volume":"88","author":"DG Allen","year":"2008","unstructured":"Allen DG, Lamb GD, Westerblad H. Skeletal muscle fatigue: cellular mechanisms. Physiol Rev. 2008;88(1):287\u2013332.","journal-title":"Physiol Rev"},{"issue":"11","key":"402_CR36","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.nmd.2008.05.017","volume":"18","author":"NC Voermans","year":"2008","unstructured":"Voermans NC, B\u00f6nnemann CG, Huijing PA, Hamel BC, van Kuppevelt TH, de Haan A, et al. Clinical and molecular overlap between myopathies and inherited connective tissue diseases. Neuromuscul Disord. 2008;18(11):843\u201356.","journal-title":"Neuromuscul Disord"},{"issue":"9","key":"402_CR37","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1002\/jor.22646","volume":"32","author":"EJ Sato","year":"2014","unstructured":"Sato EJ, Killian ML, Choi AJ, Lin E, Esparza MC, Galatz LM, et al. Skeletal muscle fibrosis and stiffness increase after rotator cuff tendon injury and neuromuscular compromise in a rat model. J Orthop Res. 2014;32(9):1111\u20136.","journal-title":"J Orthop Res"},{"issue":"3","key":"402_CR38","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1111\/j.1532-5415.2007.01092.x","volume":"55","author":"MM McDermott","year":"2007","unstructured":"McDermott MM, Hoff F, Ferrucci L, Pearce WH, Guralnik JM, Tian L, et al. Lower extremity ischemia, calf skeletal muscle characteristics, and functional impairment in peripheral arterial disease. J Am Geriatr Soc. 2007;55(3):400\u20136.","journal-title":"J Am Geriatr Soc"},{"issue":"12","key":"402_CR39","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1161\/CIRCULATIONAHA.108.842328","volume":"120","author":"MM McDermott","year":"2009","unstructured":"McDermott MM, Ferrucci L, Guralnik J, Tian L, Liu K, Hoff F, et al. Pathophysiological changes in calf muscle predict mobility loss at 2-year follow-up in men and women with peripheral arterial disease. Circulation. 2009;120(12):1048\u201355.","journal-title":"Circulation"},{"issue":"10","key":"402_CR40","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1111\/j.1532-5415.2011.03600.x","volume":"59","author":"PK Garg","year":"2011","unstructured":"Garg PK, Liu K, Ferrucci L, Guralnik JM, Criqui MH, Tian L, et al. Lower extremity nerve function, calf skeletal muscle characteristics, and functional performance in peripheral arterial disease. J Am Geriatr Soc. 2011;59(10):1855\u201363.","journal-title":"J Am Geriatr Soc"},{"issue":"13","key":"402_CR41","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/j.jacc.2011.12.019","volume":"59","author":"MM McDermott","year":"2012","unstructured":"McDermott MM, Liu K, Tian L, Guralnik JM, Criqui MH, Liao Y, et al. Calf muscle characteristics, strength measures, and mortality in peripheral arterial disease: a longitudinal study. J Am Coll Cardiol. 2012;59(13):1159\u201367.","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"402_CR42","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/nrneph.2014.112","volume":"10","author":"XH Wang","year":"2014","unstructured":"Wang XH, Mitch WE. Mechanisms of muscle wasting in chronic kidney disease. Nat Rev Nephrol. 2014;10(9):504\u201316.","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"402_CR43","doi-asserted-by":"publisher","first-page":"248","DOI":"10.2353\/ajpath.2010.091176","volume":"177","author":"A Kumar","year":"2010","unstructured":"Kumar A, Bhatnagar S, Kumar A. Matrix metalloproteinase inhibitor batimastat alleviates pathology and improves skeletal muscle function in dystrophin-deficient Mdx mice. Am J Pathol. 2010;177(1):248\u201360.","journal-title":"Am J Pathol"},{"issue":"3","key":"402_CR44","doi-asserted-by":"publisher","first-page":"333","DOI":"10.33594\/000000223","volume":"54","author":"LR Smith","year":"2020","unstructured":"Smith LR, Kok HJ, Zhang B, Chung D, Spradlin RA, Rakoczy KD, et al. Matrix metalloproteinase 13 from satellite cells is required for efficient muscle growth and regeneration. Cell Physiol Biochemistry: Int J Experimental Cell Physiol Biochem Pharmacol. 2020;54(3):333\u201353.","journal-title":"Cell Physiol Biochemistry: Int J Experimental Cell Physiol Biochem Pharmacol"},{"key":"402_CR45","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2023.1118738","volume":"10","author":"H Abbas","year":"2023","unstructured":"Abbas H, Olivere LA, Padgett ME, Schmidt CA, Gilmore BF, McCord TJ, et al. Muscle progenitor cells are required for skeletal muscle regeneration and prevention of adipogenesis after limb ischemia. Front Cardiovasc Med. 2023;10:1118738.","journal-title":"Front Cardiovasc Med"},{"key":"402_CR46","doi-asserted-by":"publisher","unstructured":"Thomas BJ, Kan-O K, Gantier MP, Simpson I, Chitty JG, Lam M, Dousha L, Gottschalk TA, Lawlor KE, Tate MD, Ruwanpura S, Seow HJ, Loveland KL, Deshpande S, Li X, Hamza K, King PT, Elias JA, Vlahos R, Bourke JE, Bardin PG. Pirfenidone Mitigates Transforming Growth Factor-\u03b2-induced Inflammation after Viral Infection. Am J Respir Cell Mol Biol. 2025 Oct;73(4):545-558.\u00a0https:\/\/doi.org\/10.1165\/rcmb.2024-0433OC. PMID: 40239009; PMCID: PMC12498362.","DOI":"10.1165\/rcmb.2024-0433OC"},{"key":"402_CR47","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.23251","author":"R Xie","year":"2023","unstructured":"Xie R, Chen SD, Li F, Yang L, Yu BL. Pirfenidone attenuates nonalcoholic fatty liver disease through activation of the nuclear factor erythroid 2-related factor 2 (Nrf2) signaling pathway. J Biochem Mol Toxicol. 2023. https:\/\/doi.org\/10.1002\/jbt.23251.","journal-title":"J Biochem Mol Toxicol"},{"issue":"2","key":"402_CR48","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1002\/mus.20681","volume":"35","author":"LE Gosselin","year":"2007","unstructured":"Gosselin LE, Williams JE, Personius K, Farkas GA. A comparison of factors associated with collagen metabolism in different skeletal muscles from dystrophic (mdx) mice: impact of Pirfenidone. Muscle Nerve. 2007;35(2):208\u201316.","journal-title":"Muscle Nerve"},{"key":"402_CR49","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.lfs.2015.12.015","volume":"145","author":"S Zanotti","year":"2016","unstructured":"Zanotti S, Bragato C, Zucchella A, Maggi L, Mantegazza R, Morandi L, et al. Anti-fibrotic effect of pirfenidone in muscle derived-fibroblasts from Duchenne muscular dystrophy patients. Life Sci. 2016;145:127\u201336.","journal-title":"Life Sci"},{"key":"402_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2022.175238","volume":"933","author":"Y Fu","year":"2022","unstructured":"Fu Y, Shi J, Qian H, Qin C, Liu L, Shen J, et al. Alleviation of cardiac fibrosis using acellular peritoneal matrix-loaded Pirfenidone nanodroplets after myocardial infarction in rats. Eur J Pharmacol. 2022;933:175238.","journal-title":"Eur J Pharmacol"},{"issue":"16","key":"402_CR51","doi-asserted-by":"publisher","first-page":"4548","DOI":"10.1111\/jcmm.17478","volume":"26","author":"N Li","year":"2022","unstructured":"Li N, Hang W, Shu H, Zhou N. Pirfenidone alleviates cardiac fibrosis induced by pressure overload via inhibiting TGF-beta1\/Smad3 signalling pathway. J Cell Mol Med. 2022;26(16):4548\u201355.","journal-title":"J Cell Mol Med"},{"key":"402_CR52","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25137302","volume":"25","author":"TA Silva","year":"2024","unstructured":"Silva TA, Thomas D, Siqueira-Neto JL, Calvet CM. Pirfenidone prevents heart fibrosis during chronic Chagas disease cardiomyopathy. Int J Mol Sci. 2024;25:13.","journal-title":"Int J Mol Sci"},{"key":"402_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.117254","volume":"178","author":"Y Yu","year":"2024","unstructured":"Yu Y, Xu Y, Chen J, Yao Y, Liu Y, Chen Y, et al. Pirfenidone improves early cardiac function following myocardial infarction by enhancing the elastin\/collagen ratio. Biomed Pharmacother. 2024;178:117254.","journal-title":"Biomed Pharmacother"},{"issue":"12","key":"402_CR54","doi-asserted-by":"publisher","first-page":"880","DOI":"10.2459\/JCM.0000000000001534","volume":"24","author":"A Aimo","year":"2023","unstructured":"Aimo A, Burchielli S, Barison A, Aquaro GD, Musetti V, Masotti S, et al. Effects of pirfenidone on scar size and ventricular remodeling after myocardial infarction: a preclinical study. J Cardiovasc Med (Hagerstown). 2023;24(12):880\u201390.","journal-title":"J Cardiovasc Med (Hagerstown)"},{"issue":"8","key":"402_CR55","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1038\/s41591-021-01452-0","volume":"27","author":"GA Lewis","year":"2021","unstructured":"Lewis GA, Dodd S, Clayton D, Bedson E, Eccleson H, Schelbert EB, et al. Pirfenidone in heart failure with preserved ejection fraction: a randomized phase 2 trial. Nat Med. 2021;27(8):1477\u201382.","journal-title":"Nat Med"},{"issue":"6","key":"402_CR56","doi-asserted-by":"publisher","first-page":"C473","DOI":"10.1152\/ajpcell.00158.2014","volume":"308","author":"MS Miller","year":"2015","unstructured":"Miller MS, Bedrin NG, Ades PA, Palmer BM, Toth MJ. Molecular determinants of force production in human skeletal muscle fibers: effects of myosin isoform expression and cross-sectional area. Am J Physiol Cell Physiol. 2015;308(6):C473-84.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"1","key":"402_CR57","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1085\/jgp.201010523","volume":"137","author":"RE Loy","year":"2011","unstructured":"Loy RE, Orynbayev M, Xu L, Andronache Z, Apostol S, Zvaritch E, et al. Muscle weakness in Ryr1(I4895T\/WT) knock-in mice as a result of reduced Ryanodine receptor Ca2\u2009+\u2009ion permeation and release from the sarcoplasmic reticulum. J Gen Physiol. 2011;137(1):43\u201357.","journal-title":"J Gen Physiol"},{"key":"402_CR58","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.155147","author":"LJ Delfinis","year":"2022","unstructured":"Delfinis LJ, Bellissimo CA, Gandhi S, DiBenedetto SN, Garibotti MC, Thuhan AK, et al. Muscle weakness precedes atrophy during cancer cachexia and is linked to muscle-specific mitochondrial stress. JCI Insight. 2022. https:\/\/doi.org\/10.1172\/jci.insight.155147.","journal-title":"JCI Insight"},{"issue":"8","key":"402_CR59","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1113\/JP270561","volume":"594","author":"RT Hepple","year":"2016","unstructured":"Hepple RT, Rice CL. Innervation and neuromuscular control in ageing skeletal muscle. J Physiol. 2016;594(8):1965\u201378.","journal-title":"J Physiol"},{"issue":"24","key":"402_CR60","doi-asserted-by":"publisher","first-page":"7361","DOI":"10.1113\/JP272487","volume":"594","author":"S Spendiff","year":"2016","unstructured":"Spendiff S, Vuda M, Gouspillou G, Aare S, Perez A, Morais JA, et al. Denervation drives mitochondrial dysfunction in skeletal muscle of octogenarians. J Physiol. 2016;594(24):7361\u201379.","journal-title":"J Physiol"},{"issue":"19","key":"402_CR61","doi-asserted-by":"publisher","first-page":"5009","DOI":"10.1113\/JP278261","volume":"597","author":"V Sonjak","year":"2019","unstructured":"Sonjak V, Jacob K, Morais JA, Rivera-Zengotita M, Spendiff S, Spake C, et al. Fidelity of muscle fibre reinnervation modulates ageing muscle impact in elderly women. J Physiol. 2019;597(19):5009\u201323.","journal-title":"J Physiol"},{"issue":"3","key":"402_CR62","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1002\/mus.22094","volume":"44","author":"AR Gillies","year":"2011","unstructured":"Gillies AR, Lieber RL. Structure and function of the skeletal muscle extracellular matrix. Muscle Nerve. 2011;44(3):318\u201331.","journal-title":"Muscle Nerve"},{"key":"402_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbiomech.2023.111593","volume":"152","author":"RL Lieber","year":"2023","unstructured":"Lieber RL, Meyer G. Structure-function relationships in the skeletal muscle extracellular matrix. J Biomech. 2023;152:111593.","journal-title":"J Biomech"},{"key":"402_CR64","doi-asserted-by":"publisher","first-page":"H424","DOI":"10.1152\/ajpheart.00121.2022","volume":"323","author":"ZR Salyers","year":"2022","unstructured":"Salyers ZR, Coleman M, Le D, Ryan TE. AAV-mediated expression of PFKFB3 in myofibers, but not endothelial cells, improves ischemic muscle function in mice with critical limb ischemia. Am J Physiol Heart Circ Physiol. 2022;323:H424\u201336.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"11","key":"402_CR65","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1161\/ATVBAHA.124.321163","volume":"44","author":"A Lejay","year":"2024","unstructured":"Lejay A, Wu WW, Kuntz SH, Feinberg MW. What is the best experimental model for developing novel therapeutics in peripheral artery disease? Arterioscler Thromb Vasc Biol. 2024;44(11):2264\u201370.","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["Skeletal Muscle"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13395-025-00402-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13395-025-00402-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13395-025-00402-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T06:41:08Z","timestamp":1763448068000},"score":1,"resource":{"primary":{"URL":"https:\/\/skeletalmusclejournal.biomedcentral.com\/articles\/10.1186\/s13395-025-00402-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,17]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["402"],"URL":"https:\/\/doi.org\/10.1186\/s13395-025-00402-5","relation":{},"ISSN":["2044-5040"],"issn-type":[{"type":"electronic","value":"2044-5040"}],"subject":[],"published":{"date-parts":[[2025,11,17]]},"assertion":[{"value":"30 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Animal Care and Use Committee of the University of Florida (Protocol 202110484).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"31"}}